DisGeNET

DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.

Source Last Updated
DisGeNET July 29, 2024
Displaying entries 42101 - 42125 of 62743 in total
Disease ID Disease Name Gene Symbol ▼ Gene ID Gene Name UniProt ID
C0014175 Endometriosis ENPP3 5169 ectonucleotide pyrophosphatase/phosphodiesterase 3 O14638
C0269102 Endometrioma ENPP3 5169 ectonucleotide pyrophosphatase/phosphodiesterase 3 O14638
C0206686 Adrenocortical carcinoma ENPP3 5169 ectonucleotide pyrophosphatase/phosphodiesterase 3 O14638
C0023467 Leukemia, Myelocytic, Acute ENPP3 5169 ectonucleotide pyrophosphatase/phosphodiesterase 3 O14638
C0023903 Liver neoplasms ENPP3 5169 ectonucleotide pyrophosphatase/phosphodiesterase 3 O14638
C0007102 Malignant tumor of colon ENPP3 5169 ectonucleotide pyrophosphatase/phosphodiesterase 3 O14638
C0008497 Choriocarcinoma ENPP3 5169 ectonucleotide pyrophosphatase/phosphodiesterase 3 O14638
C0007124 Noninfiltrating Intraductal Carcinoma ENPP3 5169 ectonucleotide pyrophosphatase/phosphodiesterase 3 O14638
C0678222 Breast Carcinoma ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0684249 Carcinoma of lung ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0020550 Hyperthyroidism ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0239946 Fibrosis, Liver ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0028754 Obesity ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0549473 Thyroid carcinoma ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0003873 Rheumatoid Arthritis ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0006142 Malignant neoplasm of breast ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C1306459 Primary malignant neoplasm ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0279607 Adult Hepatocellular Carcinoma ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C2239176 Liver carcinoma ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0699885 Carcinoma of bladder ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0205824 Liposarcoma, Dedifferentiated ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0242379 Malignant neoplasm of lung ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0016037 Fibrodysplasia Ossificans Progressiva ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0019158 Hepatitis ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C4520983 Congenital atresia of extrahepatic bile duct ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024